Outcomes of BRAF mutant metastatic melanoma (MM) patients (pts) after cessation of targeted therapy (TT) with BRAF or BRAF/MEK inhibitor(i).Natalie Jackson,Theresa Rodgers,Ida John,Denai R. Milton,Lauren Elaine Haydu,Rodabe Navroze Amaria,Adi Diab,Jennifer Leigh McQuade,Sapna Pradyuman Patel,Hussein Abdul-Hassan Tawbi,Michael K. K. Wong,Michael A. Davies,Isabella Claudia GlitzaJOURNAL OF CLINICAL ONCOLOGY（2021）引用 2|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
